Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Validating Stat3 in cancer therapy.

× No keyword cloud information.

136 in total

1. STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.

Authors: Adetola Shodeinde; Kalyani Ginjupalli; H Dan Lewis; Sheraz Riaz; Beverly E Barton
Journal: J Mol Biochem Date: 2013-02-20

2. Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.

Authors: Laura A Ekas; Timothy J Cardozo; Maria Sol Flaherty; Elizabeth A McMillan; Foster C Gonsalves; Erika A Bach
Journal: Dev Biol Date: 2010-05-23 Impact factor: 3.582

Review 3. JAK/STAT pathway dysregulation in tumors: a Drosophila perspective.

Authors: Marc Amoyel; Abigail M Anderson; Erika A Bach
Journal: Semin Cell Dev Biol Date: 2014-03-28 Impact factor: 7.727

Review 4. Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.

Authors: Nikolas Balanis; Cathleen R Carlin
Journal: Mol Cell Endocrinol Date: 2017-01-12 Impact factor: 4.102

5. Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.

Authors: Wei Yan; Bing Tu; Yun-Yun Liu; Ting-Yu Wang; Han Qiao; Zan-Jing Zhai; Hao-Wei Li; Ting-Ting Tang
Journal: Bone Res Date: 2013-12-31 Impact factor: 13.567

6. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.

Authors: Ravi P Sahu; Sanjay K Srivastava
Journal: J Natl Cancer Inst Date: 2009-01-27 Impact factor: 13.506

7. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells.

Authors: B Belinda Ding; Enguang Bi; Hongshan Chen; J Jessica Yu; B Hilda Ye
Journal: J Immunol Date: 2013-01-16 Impact factor: 5.422

8. Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.

Authors: Nelson Ung; Tracy L Putoczki; Stanley S Stylli; Irvin Ng; John M Mariadason; Timothy A Chan; Hong-Jian Zhu; Rodney B Luwor
Journal: Cancer Biol Ther Date: 2014-02-20 Impact factor: 4.742

9. Linker Variation and Structure-Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors.

Authors: Francisco Lopez-Tapia; Christine Brotherton-Pleiss; Peibin Yue; Heide Murakami; Ana Carolina Costa Araujo; Bruna Reis Dos Santos; Erin Ichinotsubo; Anna Rabkin; Raj Shah; Megan Lantz; Suzie Chen; Marcus A Tius; James Turkson
Journal: ACS Med Chem Lett Date: 2018-02-16 Impact factor: 4.345

10. STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.

Authors: H Dan Lewis; Ashley Winter; Thomas F Murphy; Snehlata Tripathi; Virendra N Pandey; Beverly E Barton
Journal: Mol Cancer Ther Date: 2008-06 Impact factor: 6.261